Skip to main content
HROW logo

HROW · Harrow, Inc. · Webcasts, Transcripts & Audio

Track HROW — free
$30.34 -0.24 (-0.79%)
Market Cap
$1.24B
Shares
37.49M
Volume · Oct 6 163.6K Avg daily vol (3M) 564.49K

Harrow, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Harrow, Inc. (HROW), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-09-09
Harrow, Inc. (HROW) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-11
Harrow, Inc. (HROW) Q2 2026 Earnings Call Transcript
Confident tone Second-half guidance and revenue acceleration IHESO pricing and demand recovery Viva franchise growth and economics
Revenue
$70.66M
▲ 10.9% YoY
Diluted EPS
$-0.46
▼ 453.8% YoY
Gross margin
71.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
Harrow, Inc. (HROW) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-12
Harrow, Inc. (HROW) Q1 2026 Earnings Call Transcript
Confident tone VEVYE demand and pricing dynamics Core growth drivers Commercial/sales force expansion
Revenue
$44.20M
▼ 7.6% YoY
Diluted EPS
$-0.74
Gross margin
61.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-03
Harrow, Inc. (HROW) Q4 2025 Earnings Call Transcript
Confident tone VEVYE growth and sales force expansion TRIESENCE relaunch and sustainability BYOOVIZ biosimilar launch and Samsung partnership
Revenue
$89.09M*
▲ 33.3% YoY
Gross margin
79.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-10
Harrow, Inc. (HROW) Q3 2025 Earnings Call Transcript
Confident tone VEVYE growth and market access TRIESENCE and specialty portfolio IHEEZO performance
Revenue
$71.64M
▲ 45.4% YoY
Diluted EPS
$0.03
Gross margin
75.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Harrow, Inc. (HROW) Q2 2025 Earnings Call
Confident tone Revenue growth and guidance VEVYE product momentum IHEEZO retina growth
Revenue
$63.74M
▲ 30.2% YoY
Diluted EPS
$0.13
Gross margin
74.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Harrow, Inc. (HROW) Q1 2025 Earnings Call Transcript
Confident tone VEVYE commercial outlook IHEEZO recovery and growth Revenue guidance and seasonality
Revenue
$47.83M
▲ 38.3% YoY
Diluted EPS
$-0.50
Gross margin
67.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
Harrow, Inc. (HROW) Q4 2024 Earnings Call
Revenue
$66.83M*
▲ 83.8% YoY
Gross margin
78.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Harrow, Inc. (HROW) Q3 2024 Earnings Call Transcript
Confident tone VEVYE dry eye product TRIESENCE relaunch IHEEZO performance
Revenue
$49.26M
▲ 43.8% YoY
Diluted EPS
$-0.12
Gross margin
75.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Harrow, Inc. (HROW) Q2 2024 Earnings Call Transcript
Confident tone VEVYE Dry Eye Franchise Success IHEEZO Retina Product Launch Market Access and Coverage Expansion
Revenue
$48.94M
▲ 46.2% YoY
Diluted EPS
$-0.18
Gross margin
74.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Harrow, Inc. (HROW) Q1 2024 Earnings Call Transcript
Confident tone VEVYE launch and dry eye franchise IHEEZO adoption and CMS reimbursement Anterior Segment product portfolio
Revenue
$34.59M
▲ 32.5% YoY
Diluted EPS
$-0.38
Gross margin
69.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-19
Harrow, Inc. (HROW) Q4 2023 Earnings Call Transcript
Confident tone VEVYE launch and dry eye market Triesence manufacturing and relaunch Pricing philosophy and patient access
Revenue
$36.35M*
▲ 78.8% YoY
Gross margin
68.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript
Revenue
$34.27M
▲ 50.1% YoY
Diluted EPS
$-0.13
Gross margin
70.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Harrow, Inc. (HROW) Q2 2023 Earnings Call Transcript
Revenue
$33.47M
▲ 43.5% YoY
Diluted EPS
$-0.14
Gross margin
70.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Harrow, Inc. (HROW) Q1 2023 Earnings Call Transcript
Revenue
$26.10M
▲ 18% YoY
Diluted EPS
$-0.22
Gross margin
68.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-23
Harrow, Inc. (HROW) Q4 2022 Earnings Call Transcript
Revenue
$20.33M*
▲ 0.7% YoY
Gross margin
69.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Harrow, Inc. (HROW) Q3 2022 Earnings Call Transcript
Revenue
$22.82M
▲ 22% YoY
Diluted EPS
$-0.24
Gross margin
70.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Harrow, Inc. (HROW) Q2 2022 Earnings Call Transcript
Revenue
$23.32M
▲ 28.6% YoY
Diluted EPS
$-0.23
Gross margin
72.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Harrow, Inc. (HROW) Q1 2022 Earnings Call Transcript
Revenue
$22.12M
▲ 43.2% YoY
Diluted EPS
$-0.09
▼ 1000% YoY
Gross margin
73.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-10
Harrow, Inc. (HROW) Q4 2021 Earnings Call Transcript
Revenue
$20.19M*
▲ 38.3% YoY
Gross margin
74.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Harrow, Inc. (HROW) Q3 2021 Earnings Call Transcript
Revenue
$18.71M
▲ 29.9% YoY
Diluted EPS
$-0.31
▼ 196.9% YoY
Gross margin
73.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
Harrow, Inc. (HROW) Q2 2021 Earnings Call Transcript
Revenue
$18.13M
▲ 125% YoY
Gross margin
75.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-14
Harrow, Inc. (HROW) Q1 2021 Earnings Call Transcript
Revenue
$15.44M
▲ 30.7% YoY
Diluted EPS
$0.01
Gross margin
75.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-08
Harrow, Inc. (HROW) Q4 2020 Earnings Call Transcript
Revenue
$14.60M*
▲ 15.8% YoY
Gross margin
73.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Harrow, Inc. (HROW) Q3 2020 Earnings Call Transcript
Revenue
$14.40M
▲ 12.9% YoY
Diluted EPS
$0.32
Gross margin
74.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Harrow, Inc. (HROW) Q2 2020 Earnings Call Transcript
Revenue
$8.06M
▼ 40.4% YoY
Diluted EPS
$-0.01
Gross margin
60.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Harrow, Inc. (HROW) Q1 2020 Earnings Call Transcript
Revenue
$11.82M
▼ 3.8% YoY
Diluted EPS
$-0.50
▼ 216.3% YoY
Gross margin
69.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-13
Harrow, Inc. (HROW) Q4 2019 Earnings Call
Revenue
$12.60M*
▲ 10.7% YoY
Gross margin
71.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–29 of 29 webcasts
Key facts CIK 1360214 CUSIP 415858109 13F (30d) 6 filings 6 filers Visit website Investor relations